The stock of Axcella Health Inc. (NASDAQ:AXLA) increased by $0.34 on Tuesday to finish at $0.45, up 298.94 percent. The last five days have seen an average of 74,491,961 shares of common stock traded. 8 times new highs were reached in the current year, with a gain of $0.1225. The average number of shares traded over the last 20 days was 21,370,701, while the average volume over the last 50 days totaled 8,743,114.
AXLA stock appreciated 148.34% since last month. On 08/25/23, the company’s shares reached a one-month low of $0.1035. The stock touched a high of $2.70 on 01/26/23, after rallying from a low of $0.10 in 52 weeks. The price of AXLA stock has risen by 37.40% or $0.1225 this year, reaching a new high 8 times. Still, the stock price is down -83.33% from the 52-week high.
Insider Transactions
AXLA stock investors should be aware that Axcella Health Inc. (AXLA) stock had its last reported insider trading activity 182 days ago on Mar 01. On Mar 01, Chief Medical Officer Koziel Margaret sold 679 shares at $0.58 each. This transaction resulted in the insider making $394. On Oct 19, Hinshaw William sold 16,000 shares at a price of US$1.56. After the transaction, the insider now owns 82,012 shares. 10% Owner Flagship Ventures Fund IV Gene had earlier bought 10,383,760 shares on Oct 13 for $1.64 a share. The transaction was completed for $17,029,366.
Financial Health
For the three months ended June 29, Axcella Health Inc.’s quick ratio was 0.80, while its current ratio was 0.80, indicating its inability to pay off its debt. Based on annual data, it had gross profit of $3.02 million and revenue of $76.99 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. AXLA’s return on assets (ROA) during the last 12 months has been -268.80%.
Earnings Surprise
According to Axcella Health Inc.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. It was predicted that Axcella Health Inc.’s quarterly earnings would be -$0.05, but it ended up being -$0.06, beating the consensus by 16.70%. EBITDA was -$3.53 million for the quarter. At the end of Axcella Health Inc.’s most recent quarter ended June 29, its liabilities totaled 11.54 million, while its total debt was $1.39 million. Equity owned by shareholders amounts to $73.69 million.
Technical Picture
Here’s a quick look at Axcella Health Inc.’s (AXLA) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 85.00%, suggesting the stock is Overbought, with a 720.25% historical volatility rate.
The stochastic %K and %D were 31.15% and 13.02% respectively, while the average true range (ATR) was 0.0729. Based on the 14-day stochastic reading of 85.66%, the RSI (14) reading is 79.97%. On the 9-day MACD Oscillator, the stock is at 0.0448, and the 14-day reading is at 0.0502.
Analyst Ratings
In its analyst report released on October 12, 2021, Noble Capital Markets began covering Axcella Health Inc. (NASDAQ: AXLA). The stock was rated as an Outperform by the brokerage firm. Analysts have assigned Axcella Health Inc. (AXLA) an Hold rating. AXLA is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 0 others recommend it as a buy.
What is AXLA’s price target for the next 12 months?
The current consensus forecast for the stock is between $1.50 and $1.50, with a median target price of $1.50. In analyzing these forecasts, the average price target given by analysts for Axcella Health Inc. (AXLA) is $1.50.
